We provide pain management billing and coding services to independent practices and ASCs, including interventional pain management billing for injections, ablations and neuromodulation. Our coders hold CPC and CCS certifications and work at 98.9% coding accuracy across our coding work. We bill all payers and work in the EHR you already use.
Pain management billing combines E/M and medication management visits with interventional procedures such as epidurals, facet injections, radiofrequency ablation and spinal cord stimulators, each billed by spinal level, side and imaging method. Most procedures need prior authorization and documented failure of conservative care, and Medicare's local coverage determinations cap how often they can be repeated. Qualigenix handles that work for pain management practices, from authorization to appeals; call 786-259-0231 to talk through your current numbers.
Spinal injection codes are built by approach, region and level. Transforaminal epidurals have a primary code for the first level (64479, 64483) and add-on codes for each additional level (64480, 64484). Facet injections follow the same pattern (64490 to 64495). Coding a two-level procedure as one, or a unilateral one as bilateral, changes the payment.
Most commercial and Medicare Advantage plans authorize epidural steroid injections, facet procedures, radiofrequency ablation and spinal cord stimulator trials and implants in advance, often per level and per side. An authorization for L4-5 does not cover L5-S1.
Fluoroscopic or CT guidance is included in the current epidural codes (62321, 62323, 64479 to 64484) and facet codes (64490 to 64495). Billing 77003 on top of them is an unbundling error. Ultrasound-guided facet injections use their own Category III codes. Whether imaging is separately billable depends on the exact code, and the note has to name the guidance used.
Bilateral procedures take modifier 50 or RT and LT, depending on the payer. Distinct procedures on the same date may need 59 or an X modifier. A same-day E/M needs modifier 25 and a separately documented decision beyond the procedure. Payers deny the whole line when the modifier doesn't match their policy.
Coverage for injections, RFA and neuromodulation differs by plan, and many plans count procedures per region per rolling 12 months. A repeat injection scheduled without checking the last date of service is a likely denial.
Medicare's local coverage determinations for epidural steroid injections and facet joint interventions set documentation requirements for repeating a procedure. For facet RFA, they require two diagnostic medial branch blocks, each with at least 80% relief, before the ablation. Repeat injections need documented pain relief and functional improvement from the last one.
Common pain management denials come from missing or level-mismatched authorizations, wrong laterality modifiers, imaging billed separately when it is included, and repeat procedures inside the payer's frequency window.
Pain practices that monitor opioid therapy also bill urine drug testing, which Medicare reviews closely. In the 2025 CERT data, two of the most frequent root causes for errors in lab tests paid outside the Medicare fee schedule were a missing risk assessment for the urine drug screen and a missing level of risk (CMS CERT 2025, Table 5). Drug testing claims need the risk assessment in the chart.
Each fix below matches a gap above, in the same order.
Our coders code each procedure from the operative note by approach, region, level and side, with primary and add-on codes matched to the levels documented.
We check each payer's authorization rules by procedure, level and side, submit the request with the conservative-care history, and track it until the number is on file.
We check every procedure for included imaging and bill guidance separately only when the code and the note support it.
We apply modifier 50, RT/LT, 59 or X modifiers, and 25 to each payer's policy, so the line is paid as performed.
Before the procedure, we confirm coverage and the date of the last procedure in that region, so repeats are scheduled outside the frequency window.
We check that the chart documents conservative care, prior relief percentages and functional change before a repeat injection or RFA goes out.
We work each pain management denial to its root cause and appeal the ones that should be paid. Across our denial management work, 79% of denials are overturned, with an average appeal turnaround under 9 days.
We track procedure frequency by region and drug testing documentation by provider, and flag patterns that would draw a payer review.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Our pain management coding covers every service line a pain management practice bills.
New patient consultations, follow-ups and medication management visits, with modifier 25 applied when a visit and a procedure happen on the same date.
Qualigenix keeps pain management billing compliant by following Medicare and payer pain management billing guidelines as written: coding each procedure to the levels, sides and imaging the note documents, checking repeat procedures against Medicare's LCD frequency and relief requirements, and billing drug testing only with the risk assessment in the chart. Underbilling leaves earned revenue unpaid. Overbilling creates audit exposure and repayment demands. We hold a 98.6% compliance and audit pass rate and an over/undercoding rate under 2%. All work is HIPAA compliant, and patient data is handled under strict security controls.

Qualigenix charges a percentage of collections, so our fee rises and falls with what your practice is paid. We bill all payers. Call 786-259-0231 for a quote based on your procedure volume and payer mix.
We code the primary level and each add-on level from the operative note, and apply modifier 50 or RT and LT according to each payer's policy.
Medicare covers medically necessary pain management visits and procedures, but its local coverage determinations set documentation and frequency rules for epidurals and facet procedures, including two diagnostic medial branch blocks with at least 80% relief before RFA. We check each repeat procedure against those rules before it is scheduled.
Yes. We take over open and aged pain management AR, sort it by payer and age, and work it alongside new claims. Across our AR work, days in AR have dropped from 54 to 36.
Yes. We submit authorization requests by procedure, level and side, with the conservative-care history the payer asks for, and track each one until the number is on file.
Not for the current epidural and facet injection codes, which include fluoroscopic or CT guidance. We bill imaging separately only when the procedure code does not include it and the note documents it.
Yes. Qualigenix is system-agnostic and has worked across 133 EMR/EHR platforms, so we work inside your current system.
Our average onboarding takes 6 days, covering system access, payer authorization rules, enrollment checks and a review of your open AR.